Can I Take Glutathione with AndroGel?

How AndroGel Works and Why the Route Matters

AndroGel is a topical testosterone formulation applied daily to the shoulders, upper arms, or abdomen. The gel delivers testosterone through the skin directly into the bloodstream. This matters for supplement interactions.

Transdermal Absorption Bypasses the Liver

Unlike oral testosterone formulations such as Jatenzo (testosterone undecanoate), which pass through the gastrointestinal tract and liver before reaching systemic circulation, transdermal testosterone avoids hepatic first-pass metabolism almost entirely [1]. The FDA-approved prescribing information for AndroGel 1.62% confirms that steady-state serum testosterone concentrations are achieved within 24 hours of daily application, with approximately 10% of the applied dose absorbed through the skin [2].

Why First-Pass Avoidance Reduces Interaction Risk

Because the testosterone from AndroGel enters the bloodstream without passing through the portal circulation first, the chance that a supplement affecting liver enzyme activity will alter testosterone levels before they reach target tissues is lower compared to oral androgens. Testosterone is still metabolized hepatically once in circulation (primarily via CYP3A4 and UGT2B17 glucuronidation), but the drug reaches therapeutic serum concentrations before that clearance begins [3].

This pharmacokinetic profile means that even supplements with known effects on hepatic conjugation pathways pose a smaller theoretical risk when paired with transdermal testosterone than they would with an oral formulation.

What Glutathione Does in the Body

Glutathione (GSH) is a tripeptide (glutamate, cysteine, glycine) synthesized in every human cell. It is the most abundant intracellular antioxidant and plays a direct role in Phase II detoxification reactions in the liver.

The Phase II Conjugation Connection

In the liver, glutathione S-transferase (GST) enzymes conjugate glutathione to electrophilic compounds, rendering them water-soluble for excretion. Testosterone and its metabolites are cleared partly through glucuronidation (via UGT enzymes) and partly through sulfation. Glutathione conjugation is not a primary clearance pathway for testosterone itself [4]. This biochemical distinction is significant: glutathione supplementation modulates GST activity, not the UGT or SULT enzymes that handle most testosterone metabolism.

Oral vs. IV Glutathione: A Critical Distinction

A randomized, double-blind, placebo-controlled trial by Richie et al. (2015) found that oral glutathione at 250 mg and 1,000 mg daily for 6 months increased body stores of GSH by 17% and 35%, respectively, with no serious adverse effects [5]. Oral absorption is gradual and produces modest increases in circulating GSH.

IV glutathione, by contrast, produces rapid spikes in plasma glutathione that are 10 to 20 times higher than oral dosing achieves. These bolus infusions, commonly administered at 600 to 2,400 mg per session in wellness clinics, transiently flood hepatic cells with reduced glutathione. While no clinical trial has measured the effect of IV glutathione on testosterone clearance specifically, the pharmacokinetic principle is straightforward: a sudden surge of a Phase II cofactor could temporarily accelerate conjugation reactions, including those affecting circulating hormones [6].

Is There a Direct Pharmacokinetic Interaction?

No published human study has tested glutathione and testosterone gel co-administration and measured changes in testosterone area-under-the-curve (AUC), peak concentration (Cmax), or clearance rates. The interaction is theoretical.

What the Literature Actually Shows

A PubMed search for "glutathione testosterone interaction" returns studies focused on glutathione's antioxidant role in the testes, not on supplement-drug interactions. Research by Agarwal et al. Demonstrated that oxidative stress (low GSH) impairs Leydig cell testosterone production in infertile men, and that antioxidant supplementation (including N-acetylcysteine, a glutathione precursor) may support endogenous testosterone synthesis [7]. This finding is relevant to men not yet on TRT. For men already receiving exogenous testosterone via AndroGel, endogenous production is suppressed by hypothalamic-pituitary-gonadal (HPG) axis feedback, making this mechanism less clinically relevant.

Pharmacodynamic Considerations

Glutathione may offer a complementary pharmacodynamic benefit rather than an interaction risk. Testosterone replacement therapy increases erythropoiesis. The Endocrine Society's 2018 clinical practice guideline recommends monitoring hematocrit, noting that TRT can raise it above 54%, increasing thrombotic risk [8]. Glutathione's antioxidant activity may help mitigate oxidative stress associated with polycythemia, though this has not been tested in a TRT-specific trial. This is a hypothesis, not a prescribing recommendation.

Dose-Separation and Practical Timing

Even without a confirmed interaction, reasonable dose separation reduces theoretical risk when combining any supplement with a prescription medication.

Recommended Timing Protocol

Apply AndroGel in the morning as directed (the prescribing information recommends application after showering and allowing the site to dry). Take oral glutathione at least 2 hours after gel application. This window allows transdermal testosterone absorption to reach its peak flux (typically 2 to 6 hours post-application) before introducing any compound that could modulate hepatic conjugation [2].

Specific Dose Ranges

Oral glutathione supplements are most commonly sold at 250 mg to 1,000 mg per day. The Richie et al. Trial used up to 1,000 mg daily without safety concerns in healthy adults [5]. Liposomal glutathione formulations claim higher bioavailability, though head-to-head comparison data with standard oral GSH in a TRT population does not exist. N-acetylcysteine (NAC), a glutathione precursor dosed at 600 to 1,800 mg daily, is an alternative that raises intracellular GSH levels more predictably than oral glutathione itself [9].

For IV glutathione: discuss timing with both the infusion provider and the prescribing clinician managing TRT. Scheduling IV glutathione sessions on alternating days from AndroGel application is impractical for a daily-use gel, so the focus should be on monitoring testosterone trough levels after initiating IV glutathione to confirm levels remain therapeutic.

Monitoring Recommendations

Standard TRT monitoring is sufficient for most men adding oral glutathione to their regimen. No additional labs are required solely because of the supplement.

Baseline and Ongoing Labs

The Endocrine Society guideline recommends the following schedule for men on testosterone therapy [8]:

• Total testosterone and free testosterone: measured 3 to 6 months after starting TRT, then annually. For AndroGel, draw the sample 2 to 8 hours after application.
• Hematocrit: at baseline, 3 to 6 months, then annually. Stop or reduce dose if hematocrit exceeds 54%.
• Hepatic panel (AST, ALT): at baseline. Transdermal testosterone carries minimal hepatotoxicity risk compared to oral androgens, but a baseline liver panel is standard practice.
• PSA and digital rectal exam: at baseline, 3 to 6 months, then per urology guidelines.

When to Add Glutathione-Specific Monitoring

If a patient is receiving IV glutathione at doses above 1,200 mg per session more than once weekly, checking testosterone trough levels 4 to 6 weeks after starting the infusion schedule is reasonable. A drop in trough testosterone below the therapeutic range (300 to 1,000 ng/dL per the Endocrine Society) would warrant dose adjustment of AndroGel or reconsideration of IV glutathione frequency [8].

Patients taking NAC at high doses (above 1,200 mg/day) should have hepatic transaminases checked at 3 months, as NAC can paradoxically cause elevated liver enzymes in rare cases [10].

Special Populations and Additional Considerations

Men with Pre-Existing Liver Disease

Men with hepatic impairment metabolize testosterone differently. Reduced UGT activity in cirrhotic livers slows testosterone clearance, potentially leading to supratherapeutic levels [3]. Adding glutathione supplementation in this population introduces a variable that has not been studied. The conservative approach: clear it with the hepatologist managing the liver condition before starting glutathione.

Men Taking Other CYP3A4-Affecting Supplements or Medications

Testosterone is partially metabolized by CYP3A4. Men already taking strong CYP3A4 inhibitors (ketoconazole, ritonavir) or inducers (carbamazepine, St. John's Wort) have an altered baseline for testosterone clearance. Layering glutathione supplementation onto this background is unlikely to produce a clinically meaningful additional effect, but the cumulative uncertainty argues for closer lab monitoring.

Fertility Considerations

Men using AndroGel for hypogonadism who wish to preserve fertility face a separate issue: exogenous testosterone suppresses spermatogenesis via HPG axis suppression. Glutathione and NAC have been studied as adjuncts to improve sperm quality in subfertile men not on TRT. A meta-analysis by Smits et al. (2019) found that antioxidant supplementation improved sperm motility and concentration, but these benefits apply to men with intact endogenous testosterone production, not men receiving exogenous testosterone [11].

What to Do If You Are Already Taking Both

If you are currently using AndroGel and oral glutathione without issues, there is no evidence-based reason to stop either one. Check your most recent labs. If total testosterone, hematocrit, and liver enzymes are within expected ranges, your current combination is likely safe to continue.

If you are considering adding glutathione to an existing AndroGel prescription:

1. Confirm the glutathione formulation (oral, liposomal, or IV) and dose with your prescriber.
2. Start at the lower end of the dosing range (250 mg oral glutathione daily).
3. Separate dosing by at least 2 hours from AndroGel application.
4. Recheck testosterone trough levels at your next scheduled lab draw (or at 6 weeks if no draw is upcoming).
5. Report any new symptoms (skin irritation at the gel site, fatigue, mood changes) that could signal altered testosterone levels.

Men receiving IV glutathione should provide their TRT prescriber with the infusion dose and frequency so that testosterone monitoring can be adjusted accordingly. The Endocrine Society recommends measuring total testosterone at trough for transdermal formulations to detect subtherapeutic dosing [8].